212 related articles for article (PubMed ID: 12368312)
21. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
Orange JS; Wang B; Terhorst C; Biron CA
J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells.
Kawanishi Y; Hayashi N; Katayama K; Ueda K; Takehara T; Miyoshi E; Mita E; Kasahara A; Fusamoto H; Kamada T
J Med Virol; 1995 Nov; 47(3):272-7. PubMed ID: 8551280
[TBL] [Abstract][Full Text] [Related]
23. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
[TBL] [Abstract][Full Text] [Related]
24. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.
Li M; Zhou ZH; Sun XH; Zhang X; Zhu XJ; Jin SG; Jiang Y; Gao YT; Li CZ; Gao YQ
Hepatol Int; 2016 Jul; 10(4):594-601. PubMed ID: 26924524
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
26. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.
Caselmann WH; Meyer M; Scholz S; Hofschneider PH; Koshy R
J Infect Dis; 1992 Nov; 166(5):966-71. PubMed ID: 1328410
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver.
Kakimi K; Lane TE; Chisari FV; Guidotti LG
J Immunol; 2001 Dec; 167(12):6701-5. PubMed ID: 11739482
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
29. A synergistic interferon-gamma production is induced by mouse hepatitis virus in interleukin-12 (IL-12)/IL-18-activated natural killer cells and modulated by carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1a receptor.
Jacques A; Bleau C; Turbide C; Beauchemin N; Lamontagne L
Immunology; 2009 Sep; 128(1 Suppl):e551-61. PubMed ID: 19740316
[TBL] [Abstract][Full Text] [Related]
30. Bortezomib inhibits hepatitis B virus replication in transgenic mice.
Bandi P; Garcia ML; Booth CJ; Chisari FV; Robek MD
Antimicrob Agents Chemother; 2010 Feb; 54(2):749-56. PubMed ID: 19949053
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
32. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
33. Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1).
Li Y; Xie J; Xu X; Liu L; Wan Y; Liu Y; Zhu C; Zhu Y
J Biol Chem; 2013 Jul; 288(29):20927-20941. PubMed ID: 23729669
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-21 inhibits HBV replication in vitro.
Li HJ; Kang FB; Li BS; Yang XY; Zhang YG; Sun DX
Antivir Ther; 2015; 20(6):583-90. PubMed ID: 25774942
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-35 stimulates hepatitis B virus transcription and replication by targeting transcription factor HNF4α.
Tao NN; Gong R; Chen X; He L; Ren F; Yu HB; Chen J; Ren JH
J Gen Virol; 2018 May; 99(5):645-654. PubMed ID: 29561254
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.
Parvez MK; Sehgal D; Sarin SK; Basir SF; Jameel S
World J Gastroenterol; 2006 May; 12(19):3006-14. PubMed ID: 16718779
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways.
Guidotti LG; Guilhot S; Chisari FV
J Virol; 1994 Mar; 68(3):1265-70. PubMed ID: 8107192
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress.
Togashi H; Ohno S; Matsuo T; Watanabe H; Saito T; Shinzawa H; Takahashi T
Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):407-17. PubMed ID: 11589367
[TBL] [Abstract][Full Text] [Related]
39. Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity.
Rigopoulou EI; Suri D; Chokshi S; Mullerova I; Rice S; Tedder RS; Williams R; Naoumov NV
Hepatology; 2005 Nov; 42(5):1028-36. PubMed ID: 16250037
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model.
Nagahata T; Araki K; Yamamura K; Matsubara K
Antimicrob Agents Chemother; 1992 Sep; 36(9):2042-5. PubMed ID: 1416898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
